Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Palma Serasih Tbk. (PSGO) Price & Performance

Indofarma Tbk.Trade
Palma Serasih Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Palma Serasih Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Palma Serasih Tbk. trades at Rp193 (market cap 3.66T, 310.3K 24h volume). The key difference: Palma Serasih Tbk. is far larger — about 9.4× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFPSGO
Market Cap
390.51B3.66T
Volume
310.3K
Lot
3.1K
Turnover
60.1M
Average Price
193.68
Value
60.1M
Indicative Equilibrium Price
193
Indicative Equilibrium Volume
200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
PSGO
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Palma Serasih Tbk.

PT. Palma Serasih Tbk (the Company) was established in Jakarta based on Notarial Deed of Besri Zakaria,S.H. No.1 dated June 3, 2008. PT Jalinan kasih Sesama is the parent entity and the ultimate parent entity of the Group.

Read more on PSGO